Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series | Annals of Internal Medicine

Background: The antibody response after 2 doses of an mRNA vaccine against SARS-CoV-2 is excellent in the general population (1), but the response is different in recipients of solid organ transplants. For example, we have found markedly attenuated antibody responses in transplant recipients after 2 doses of an mRNA vaccine against SARS-CoV-2 (2). In addition, reports of COVID-19 breakthrough…

Read the full article here

Source: www.acpjournals.org

Categories: General Medicine Journals and Societies, Latest Headlines

Tags: covid19, OrganTransplant, vaccinebooster

Tweets with this article

Annals of Int Med

New research from @HopkinsMedicine found that a third dose of #COVID19 vaccine increased antibody levels in #organtransplant recipients with a suboptimal response following standard 2-dose vaccination https://t.co/EV0QqGe7hG. #vaccinebooster https://t.co/vtR5mDGVGl

Excessive Alcohol Use and Alcohol Use Disorders: A Policy Brief of the American College of Physicians | Annals of Internal Medicine

Alcohol is used by more people in the United States than tobacco, electronic nicotine delivery systems, or illicit drugs. Several health conditions, including cancer, cardiovascular…

Annals of Int Med April 23, 2024

Effect of Health Service Area on Primary Care Physician Provision of Low-Value Cancer Screening | Annals of Internal Medicine

Background: Using a health systems approach to investigate low-value care (LVC) may provide insights into structural drivers of this pervasive problem. Objective: To evaluate the…

Annals of Int Med April 23, 2024

Historical Redlining and Present-Day Nonsuicide Firearm Fatalities | Annals of Internal Medicine

Background: Redlining began in the 1930s with the Home Owners’ Loan Corporation (HOLC); this discriminatory practice limited mortgage availability and reinforced concentrated poverty that still…

Annals of Int Med April 23, 2024

New Antibiotics for Resistant Infections: What Happens After Approval? | Annals of Internal Medicine

In their article, Strich and colleagues report that despite development and approval of 7 new antibiotics active against multidrug-resistant gram-negative bacteria in the last 10…

Carlos del Rio April 23, 2024

Comparison of Hospital Mortality and Readmission Rates by Physician and Patient Sex | Annals of Internal Medicine

Background: Little is known as to whether the effects of physician sex on patients’ clinical outcomes vary by patient sex. Objective: To examine whether the…

Ash Paul April 23, 2024

Comparison of Hospital Mortality and Readmission Rates by Physician and Patient Sex | Annals of Internal Medicine

Background: Little is known as to whether the effects of physician sex on patients’ clinical outcomes vary by patient sex. Objective: To examine whether the…

Ash Paul April 23, 2024

Information for Authors | Annals of Internal Medicine: Clinical Cases

Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…

Circulation April 22, 2024

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians | Annals of Internal Medicine

Description: The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline…

Annals of Int Med April 22, 2024

Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis: A Case–Control Study: Annals of Internal Medicine: Vol 161, No 3

Background: Idiopathic retroperitoneal fibrosis (RPF) is a rare disease. Asbestos exposure has been proposed as a risk factor for idiopathic RPF. Objective: To investigate the…

Annals of Int Med April 20, 2024

Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study: Annals of Internal Medicine: Vol 0, No 0

Background: According to drug labels, the frequency of thiazide-induced hyponatremia is unknown or uncommon to very rare (that is, <1 in 10 000 to <1…

Annals of Int Med April 20, 2024

Related Articles